title: High-dose recombinant human erythropoietin for "low-risk" myelodysplastic patients: is more better?
authors.affiliation: Department of Hemato-oncology, IRCCS San Martino IST, Genoa, Italy. balleari@unige.it.
authors.forename: Enrico
authors.initials: E
authors.lastname: Balleari
authors.affiliation: Department of Hemato-oncology, IRCCS San Martino IST, Genoa, Italy.
authors.forename: Lisette Del
authors.initials: LD
authors.lastname: Corso